Venture Funding and the NIH SBIR Program (2009) / Chapter Skim
Currently Skimming:
4 Focus on the Top 200 Award Winners
4 Focus on the Top 200 Award Winners
Pages 39-42
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 39... ...
The 51 firms among the top 200 NIH Phase II award winners identified as venture-funded are listed in Appendix A In aggregate, these 51 firms received a total of $272 million in NIH funding (Phase I and Phase II awards)
|
From page 40... ...
An alternative view is that resources available to venture-funded firms are likely to result in greater success in garnering SBIR awards -- a point argued by some supporters of the SBA ruling. This view would seem to be prima facie supported by the data in Table 4-1, which shows that two-thirds of SBIR award recipients received their first Phase II funding after their first venture round.
|
From page 41... ...
received their first Phase II funding after their first venture round. For these firms, it appears that SBIR funding is typically auxiliary or complementary to the venture funding they have already received.3 This view is supported by case studies completed for the NRC report on the NIH SBIR program.
|
From page 42... ...
This is an important conclusion. 4This evidence comes from case studies of firms that have won SBIR awards conducted as a part of the National Research Council's comprehensive assessment of the SBIR program.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.